Corrigendum to "Plasma endoxifen and 4-hydroxytamoxifen levels in CYP2D6(C100T) carrying breast cancer patients and association with serum cholesterol" [Toxicology and Applied Pharmacology, 378 (2019) 114619].

Ta-Chung Chao Wen-Chi Pan Yi-Fang Tsai Yueh-Ching Chou Yu-Rong Liu Sheng-Fan Wang Ying-Jen Chen Pavel Souček Yune-Fang Ueng

Toxicol Appl Pharmacol

National Research Institute of Chinese Medicine, Taipei, Taiwan; Department and Institute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei, Taiwan; Institute of Biopharmaceutical Sciences, School of Pharmacy, National Yang-Ming University, Taipei, Taiwan; Institute of Medical Sciences, Taipei Medical University, Taipei, Taiwan. Electronic address:

Published: October 2019

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.taap.2019.114701	DOI Listing

Publication Analysis

Top Keywords

corrigendum "plasma

"plasma endoxifen

endoxifen 4-hydroxytamoxifen

4-hydroxytamoxifen levels

levels cyp2d6c100t

cyp2d6c100t carrying

carrying breast

breast cancer

cancer patients

patients association

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!